Effect of a pharmacist on Adverse drug events and medication errors In outpatients with cardiovascular disease

Michael Murray, Mary E. Ritchey, Jingwei Wu, Wanzhu Tu

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Background: Adverse drug events and medication errors are threats to quality care. Inpatient studies suggest that a pharmacist may reduce these events, but outpatient studies have not been forthcoming. Methods: We conducted a pooled analysis of 2 randomized controlled trials to determine the effect of pharmacist intervention on adverse drug events and medication errors. We studied 800 outpatient cases of hypertension stratified into complicated (n=535) and uncomplicated (n=265). Patients in the complicated stratum had heart failure or other cardiovascular complication. Computer programs examined 1-year electronic record data to identify events classified as adverse drug events and preventable or potential adverse drug events. Medication errors included preventable and potential adverse drug events. Results: Of the 800 participants (mean [SD] age, 59 [10] years), 484 (90.5%) and 258 (97.4%) participants remained in the complicated and uncomplicated strata, respectively, at 12 months. Compared with the control group, the risk of any event was 34% lower in the intervention group (risk ratio, 0.66; 95% confidence interval [CI], 0.50-0.88), including a lower risk of adverse drug events (risk ratio, 0.65; 95% CI, 0.47-0.90), preventable adverse drug events (risk ratio, 0.52; 95% CI, 0.25-1.09), potential adverse drug events (risk ratio, 0.70; 95% CI, 0.40-1.22), and medication errors (risk ratio, 0.63; 95% CI, 0.40-0.98). Conclusions: This post hoc analysis suggests that pharmacist intervention to improve medication use in outpatients with cardiovascular disease decreases the risk of adverse drug events and medication errors. Further studies are needed to confirm this finding. Trial Registration: clinicaltrials.gov Identifiers: NCT00388622 and NCT00388817

Original languageEnglish
Pages (from-to)757-763
Number of pages7
JournalArchives of Internal Medicine
Volume169
Issue number8
DOIs
StatePublished - Apr 27 2009

Fingerprint

Medication Errors
Drug-Related Side Effects and Adverse Reactions
Pharmacists
Outpatients
Cardiovascular Diseases
Odds Ratio
Confidence Intervals
Quality of Health Care
Inpatients
Software
Randomized Controlled Trials
Heart Failure
Hypertension
Control Groups

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Effect of a pharmacist on Adverse drug events and medication errors In outpatients with cardiovascular disease. / Murray, Michael; Ritchey, Mary E.; Wu, Jingwei; Tu, Wanzhu.

In: Archives of Internal Medicine, Vol. 169, No. 8, 27.04.2009, p. 757-763.

Research output: Contribution to journalArticle

@article{89b031e981db45e68bce41786a9d81c8,
title = "Effect of a pharmacist on Adverse drug events and medication errors In outpatients with cardiovascular disease",
abstract = "Background: Adverse drug events and medication errors are threats to quality care. Inpatient studies suggest that a pharmacist may reduce these events, but outpatient studies have not been forthcoming. Methods: We conducted a pooled analysis of 2 randomized controlled trials to determine the effect of pharmacist intervention on adverse drug events and medication errors. We studied 800 outpatient cases of hypertension stratified into complicated (n=535) and uncomplicated (n=265). Patients in the complicated stratum had heart failure or other cardiovascular complication. Computer programs examined 1-year electronic record data to identify events classified as adverse drug events and preventable or potential adverse drug events. Medication errors included preventable and potential adverse drug events. Results: Of the 800 participants (mean [SD] age, 59 [10] years), 484 (90.5{\%}) and 258 (97.4{\%}) participants remained in the complicated and uncomplicated strata, respectively, at 12 months. Compared with the control group, the risk of any event was 34{\%} lower in the intervention group (risk ratio, 0.66; 95{\%} confidence interval [CI], 0.50-0.88), including a lower risk of adverse drug events (risk ratio, 0.65; 95{\%} CI, 0.47-0.90), preventable adverse drug events (risk ratio, 0.52; 95{\%} CI, 0.25-1.09), potential adverse drug events (risk ratio, 0.70; 95{\%} CI, 0.40-1.22), and medication errors (risk ratio, 0.63; 95{\%} CI, 0.40-0.98). Conclusions: This post hoc analysis suggests that pharmacist intervention to improve medication use in outpatients with cardiovascular disease decreases the risk of adverse drug events and medication errors. Further studies are needed to confirm this finding. Trial Registration: clinicaltrials.gov Identifiers: NCT00388622 and NCT00388817",
author = "Michael Murray and Ritchey, {Mary E.} and Jingwei Wu and Wanzhu Tu",
year = "2009",
month = "4",
day = "27",
doi = "10.1001/archinternmed.2009.59",
language = "English",
volume = "169",
pages = "757--763",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Effect of a pharmacist on Adverse drug events and medication errors In outpatients with cardiovascular disease

AU - Murray, Michael

AU - Ritchey, Mary E.

AU - Wu, Jingwei

AU - Tu, Wanzhu

PY - 2009/4/27

Y1 - 2009/4/27

N2 - Background: Adverse drug events and medication errors are threats to quality care. Inpatient studies suggest that a pharmacist may reduce these events, but outpatient studies have not been forthcoming. Methods: We conducted a pooled analysis of 2 randomized controlled trials to determine the effect of pharmacist intervention on adverse drug events and medication errors. We studied 800 outpatient cases of hypertension stratified into complicated (n=535) and uncomplicated (n=265). Patients in the complicated stratum had heart failure or other cardiovascular complication. Computer programs examined 1-year electronic record data to identify events classified as adverse drug events and preventable or potential adverse drug events. Medication errors included preventable and potential adverse drug events. Results: Of the 800 participants (mean [SD] age, 59 [10] years), 484 (90.5%) and 258 (97.4%) participants remained in the complicated and uncomplicated strata, respectively, at 12 months. Compared with the control group, the risk of any event was 34% lower in the intervention group (risk ratio, 0.66; 95% confidence interval [CI], 0.50-0.88), including a lower risk of adverse drug events (risk ratio, 0.65; 95% CI, 0.47-0.90), preventable adverse drug events (risk ratio, 0.52; 95% CI, 0.25-1.09), potential adverse drug events (risk ratio, 0.70; 95% CI, 0.40-1.22), and medication errors (risk ratio, 0.63; 95% CI, 0.40-0.98). Conclusions: This post hoc analysis suggests that pharmacist intervention to improve medication use in outpatients with cardiovascular disease decreases the risk of adverse drug events and medication errors. Further studies are needed to confirm this finding. Trial Registration: clinicaltrials.gov Identifiers: NCT00388622 and NCT00388817

AB - Background: Adverse drug events and medication errors are threats to quality care. Inpatient studies suggest that a pharmacist may reduce these events, but outpatient studies have not been forthcoming. Methods: We conducted a pooled analysis of 2 randomized controlled trials to determine the effect of pharmacist intervention on adverse drug events and medication errors. We studied 800 outpatient cases of hypertension stratified into complicated (n=535) and uncomplicated (n=265). Patients in the complicated stratum had heart failure or other cardiovascular complication. Computer programs examined 1-year electronic record data to identify events classified as adverse drug events and preventable or potential adverse drug events. Medication errors included preventable and potential adverse drug events. Results: Of the 800 participants (mean [SD] age, 59 [10] years), 484 (90.5%) and 258 (97.4%) participants remained in the complicated and uncomplicated strata, respectively, at 12 months. Compared with the control group, the risk of any event was 34% lower in the intervention group (risk ratio, 0.66; 95% confidence interval [CI], 0.50-0.88), including a lower risk of adverse drug events (risk ratio, 0.65; 95% CI, 0.47-0.90), preventable adverse drug events (risk ratio, 0.52; 95% CI, 0.25-1.09), potential adverse drug events (risk ratio, 0.70; 95% CI, 0.40-1.22), and medication errors (risk ratio, 0.63; 95% CI, 0.40-0.98). Conclusions: This post hoc analysis suggests that pharmacist intervention to improve medication use in outpatients with cardiovascular disease decreases the risk of adverse drug events and medication errors. Further studies are needed to confirm this finding. Trial Registration: clinicaltrials.gov Identifiers: NCT00388622 and NCT00388817

UR - http://www.scopus.com/inward/record.url?scp=65649100478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649100478&partnerID=8YFLogxK

U2 - 10.1001/archinternmed.2009.59

DO - 10.1001/archinternmed.2009.59

M3 - Article

C2 - 19398687

AN - SCOPUS:65649100478

VL - 169

SP - 757

EP - 763

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 8

ER -